H3B-6527
- CAS No.
- 1702259-66-2
- Chemical Name:
- H3B-6527
- Synonyms
- CS-2347;H3B-6527;H3 Biomedicine;H3B6527;H3B 6527;Eisai/H3 Biomedicine;H3B-6527, 10 mM in DMSO;H-3B-6527,H3B6527,H3B 6527;H3B-6527, 98%, a highly selective FGFR4 inhibitor with potent antitumour activity;N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide;2-Propenamide, N-[2-[[6-[[[(2,6-dichloro-3,5-dimethoxyphenyl)amino]carbonyl]methylamino]-4-pyrimidinyl]amino]-5-(4-ethyl-1-piperazinyl)phenyl]-
- CBNumber:
- CB23146613
- Molecular Formula:
- C29H34Cl2N8O4
- Molecular Weight:
- 629.54
- MDL Number:
- MFCD30377210
- MOL File:
- 1702259-66-2.mol
Boiling point | 832.1±65.0 °C(Predicted) |
---|---|
Density | 1.373±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO:50.0(Max Conc. mg/mL);79.42(Max Conc. mM) |
form | A solid |
pka | 11.00±0.70(Predicted) |
color | White to khaki |
FDA UNII | 4HTE364XIK |
H3B-6527 price More Price(13)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 26072 | H3B-6527 ≥98% | 1702259-66-2 | 1mg | $81 | 2024-03-01 | Buy |
Cayman Chemical | 26072 | H3B-6527 ≥98% | 1702259-66-2 | 5mg | $238 | 2024-03-01 | Buy |
Cayman Chemical | 26072 | H3B-6527 ≥98% | 1702259-66-2 | 10mg | $435 | 2024-03-01 | Buy |
Cayman Chemical | 26072 | H3B-6527 ≥98% | 1702259-66-2 | 25mg | $887 | 2024-03-01 | Buy |
AK Scientific | 2308EF | H3B-6527 | 1702259-66-2 | 1mg | $187 | 2021-12-16 | Buy |
H3B-6527 Chemical Properties,Uses,Production
Uses
H3B-6527 is an orally active, highly selective and covalent FGFR4 inhibitor with an IC50 of <1.2 nM. H3B-6527 has at least 250-fold selectivity over FGFR1-3 with IC50s of 320 nM, 1290 nM and 1060 nM respectively. H3B-6527 has potent anti-cancer activity[1].
Biological Activity
H3B-6527 is a highly selective covalent FGFR4 inhibitor with IC50 < 1.2 nM, with >250-fold selectivity for FGFR4 over FGFR1-3 (IC50s of 320, 1290 and 1290 for FGFR1-3, respectively) 1060 nM).
in vitro
H3B-6527 has a strong inhibitory effect on FGFR4 with IC50 less than 1.2 nM. TAOK2, JNK2 and CSF1R were less sensitive to H3B-6527 treatment with IC50s of 690, >10000 and >10000 nmol/L, respectively. Treatment of Hep3B cells with H3B-6527 resulted in a concentration-dependent activation of caspase-3/7. It inhibits FGFR4 signaling, inhibits proliferation, and causes apoptosis in HCC cells.
in vivo
In a mouse model of Hep3B hepatocarcinoma xenografts, H3B-6527 had dose-proportional plasma exposure (greater than tumor exposure; doses tested were 30, 100, and 300 mg/kg). The pharmacodynamic response of H3B-6527 was detected, and it was found that CYP7A1 mRNA and pERK1/2 protein levels showed a concentration-dependent response, and higher concentrations would lead to a more durable response. In both subcutaneous Hep3B xenograft models and orthotopic xenograft models, oral administration of it (twice a day) significantly inhibited the growth of xenografts. Palbociclib enhanced the potency of it and promoted tumor regression in the JHH-7 model, whereas it single-agent administration only caused tumor growth arrest.
IC 50
FGFR4: <1.2 nM (IC50); FGFR1: 320 nM (IC50); FGFR2: 1290 nM (IC50); FGFR3: 1060 nM (IC50)
References
[1] Joshi JJ, et al. H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven HepatocellularCarcinoma. Cancer Res. 2017 Dec 15;77(24):6999-7013. DOI:10.1158/0008-5472.CAN-17-1865
H3B-6527 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
AFINE CHEMICALS LIMITED | +86-0571-85134551 | sales@afinechem.com | China | 15417 | 58 |
Finetech Industry Limited | +86-27-8746-5837 +8619945049750 | info@finetechnology-ind.com | China | 9642 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38663 | 58 | |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8467 | 58 |
1702259-66-2(H3B-6527)Related Search:
1of3